In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis: Short term cellular and molecular effects

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1646-1653

  Lorenz, Hanns Martin ^a   Antoni, Christian ^a   Valerius, Thomas ^a   Repp, Roland ^a   Grünke, Mathias ^a   Schwerdtner, Nives ^a   Nüßlein, Hubert ^a   Woody, Jim ^b   Kalden, Joachim R ^a   Manger, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY CA 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GRANULOCYTE FUNCTION; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029671297     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Moreland, L W., R. P Bucy, A. Tilden, P. W Pratt, A. R LoBuglio, M. Khazaeli, M. P. Everson, P. Daddona, J. Ghrayeb, C Kilgarriff, M. E Sanders, and W. J Koopman. 1993 Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum. 36:307.
2. Van der Lubbe, P. A., C Reiter, F. C Breedveld, K. Krüger, M Schattenkirchner, M E. Sanders, and O Riethmüller. 1993. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis Arthritis Rheum. 36:1375.
3. Horneff, G., G. R. Burmesler, F. Emmerich, and J. R Kalden. 1991. Treatment of rheumatoid arthntis with an anti-CD4 monoclonal antibody. Anhritis Rheum. 34 129.
4. 4 antibody M-T151. Arthritis Rheum. 34:525
5. Didry, C., P. Portales, M. Andary, J Brochier, B. Combe, J Clot, and J Sany. 1991 Treatment of rheumatoid arthritis with monoclonal anti-CD4 antibodies Clinical results. Arthritis Rheum. 34:S92.
6. Strand, V., P. E. Lipsky. G. W. Cannon, L H. Calabrese, C. Wiesenhutter, S B Cohen, N. J. Olsen, M L. Lee, T. J. Lorenz, and B. Nelson. 1993. Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis Arthritis Rheum. 36:620.
7. Kirkham, B. W., F. Thien, B. K. Pelton, C. Pitzalis, P Amlot, A M. Denman, and G. S. Panayi. 1992. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis. J. Rheumatol 19:1348.
8. Moreland, L. W., K. Lea Sewell, W. F Sullivan, R. H. Shmerling, K. C Parker, W. G. Swartz, T G. Woodworth, D. E Trentham, and W. J Koopman 1993 Double-blind placebo-controlled phase Il trial of diphtheria-interleukin-2 fusion toxin (DAB4861L-2) in patients with refractory rheumatoid arthritis Anthritis Rheum. 36:S39.
9. Kremer, J. M., G. F Rigby, W. F. C Petrillo, S J. Plehn, T. G Woodworth, K. C. Parker, and G S Taintor. 1994. Phase I/II open-label mal of DAB389IL-2 administered to patients with active Rheumatoid Arthritis receiving treatment with methotrexate. Arthritis Rheum. 37:S341.
10. Isaacs, J. D., R. A. Watts, B. L. Hazleman, G Hale, M T. Keogan, S. P. Cobhold, and H. Waldmann 1992. Humanised monoclonal antibody therapy for rheumatoid arthritis Lancet 340:748.
11. Kavanaugh, A. F., L S. Davis, L. A Nichols, S. H. Norris, R. Rothlein. L A Scharschmidt, and P. E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule I. Arthritis Rheum 37:992.
12. Wendung, D., E. Radacot, and J. Wijdenes. 1993. Treatment of severe Rheumatoid Arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 20 259.
13. Elliott, M. J., R. N. Maim. M. Feldmann, A Long-Fox, P Charles, P. Katsikis, F M. Brennan, J. Walker, H. Bijl, J. Ghrayeb, and J. Woody. 1993 Treatment of rheumatoid arthritis with chimenc monoclonal antibodies to TNF-α Arthritis Rheum 36:1681.
14. Moreland, L W., G. R. Margolies, L. W. Heck, P A. Saway, C. Jacobs, C. Beck, C. Blosch, and W. J. Koopman. 1994. Soluble tumor necrosis factor receptor (sTNF): results of a phase 1 dose escalation study in patients with rheumatoid arthritis. Arthritis Rheum 37:S295.
15. Drevlow, B., R Lovis, M. A. Haag, J. Sinacore, C. Jacobs, C. Blosch, C Beck, A. Landay, L. Moreland, and R. M. Pope. 1994. Phase I study of recombinant human interleukiu-1 receptor (RHU IL-IR) administered subcutaneously in patients with active rheumatoid arthritis. Anhritis Rheum. 37:S339
16. Beutler, B., and A Cerami, 1988. The common mediator of shock, cachexia and rumor necrosis. Adv. Immunol. 42:213.
17. Buchan, G., K. Barrett, M. Turner, D. Chantry, R. N. Maini, and M. Feldmann. 1988 Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin. Exp Immunol 73:449.
18. Firebtein, G. S., J. M. Alvaro-Garcia, and R. Maki. 1990 Quantitative analysis of cytokine gene expression in rheumatoid arthritis J Immunol. 144:3347.
19. Saxne, T., M. A. Palladino, D. Hemegard, N Talal, and F. A. Wollheim. 1988 Detection of tumor necrosis factor α, but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31:1041.
20. Goldfied, A. E., J. L. Strominger, and C Doyle. 1991 Human tumor necrosis factor a gene regulation in phorbol ester stimulated T and B cell lines. J Exp. Med. 174:73.
21. Sung, S.-S. J , L K. L Jung, J. A Walters, W. Chen, C Y. Wang, and S M. Fu. 1988. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 168:1539
22. Sung, S -S. J , J. M. Bjorndahl, C. Y. Wang, H T Kao, and S M. Fu. 1988. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med. 167:937.
23. Brennan, F. M., D Chantry, A Jackson, R. N Maini, and M. Feldmann 1989. Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 334:244.
24. Williams, R. O., M. Feldmann, and R. N Maim 1992 Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad Sci. USA 89:9784
25. Elliott, M J., R. N Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveldt, J. D. Macfarlane, H Bijl, and J N. Woody. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
26. Arnett, F. C., S. M Edworthy, D. A Bloch, D. J McShane, J. F Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M H. Liang, H. S Luthra, T A. Medsger, D. M. Mitchell, D. H. Neustadt, R S. Pinals, J G. Schaller, J. T. Sharp, R. L Wilder, and G. G. Hunder. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
27. Knight, D. M , H. Trinh, and J. Le 1993. Construction and initial characterisation of a mouse-human chimaeric anti-TNF antibody. Mol. Immunol. 30:1443.
28. Lagoo-Deenadayalan, S., A. S. Lagoo, W H. Barber, and K. J Hardy. 1993 A standarized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 12:59.
29. Smith, J. A , and M. J Weidemonn. 1993 Further characterization of the neutrophil oxidative burst bv flow cytometry. J. Immunol. Methods 162:261.
30. Krüger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Müller, J. Knoller, and M. Köller. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297.
31. Huber, C., J. R. Batchelor, and D. Fuchs. 1984 Immune response-associated production of neopterin Release from macrophages primarily under the control of Interferon gamma J Exp. Med. 160:310.
32. Gerritsen, M. F., K. A. Kelley, G. Ligon, C. A. Perry, C. P Shen, A. Szezepanski, and W. W Carley. 1993 Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium. Arthritis Rheum. 36:593.
33. Tessier, P., M. Audette, P. Cattaruzzi, and S. R, McColl. 1993. Upregulation by tumor necrosis factor alpha of intercellular adhesion molecule-1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum. 36:1528.
34. Braunstein, J., J. Allendorf, M. Reister, T. Dengler, E. Amtmann, R. Schmidt, U Moebius, and S. Meuer. 1994. How are soluble forms of ICAM-I (sCD54) and LFA-3 (sCD58) generated? Immunobiology 191:193
35. Verwilghen, J., R Lovis, M De Boer, P. S. Linsley, G. K Haines, A. E. Koch, and R. M. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells J. Immunol. 153:1378.
36. + monocytes as prognostic parameter for disease outcome of septic disease. In: Immunotherapeutic Advances K. N. Masihi and W. Lange, eds Springer-Verlag, Heidelberg, London, New York, p. 277.
37. Fugger, R , E Zadrobilek, P. Gotzinger, S. Klimann, M Rogy, S. Winkler, H. Andel, M Mittelbock, E. Roth, and F. Schulz. 1993. Perioperative TNF-α and IL-6 concentrations correlate with septic state, organ function, and APAPHF, II scores in intraabdominal infection Eur. J. Surg 159:525.
38. Cunha, F. Q., S. Poole, B. B. Lorenzetti, and S H. Ferreira. 1992 The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 107:660.